Modulation of stimulatory and non-stimulatory myeloid cells
Abstract:
Provided herein are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an antigen binding protein such as an antibody or antigen binding fragment thereof.
Public/Granted literature
Information query
Patent Agency Ranking
0/0